Webinar Program Details



Addressing the Prevention, Treatment and Management of VTE in Pregnancy: A Review of the Most Recent (2018) ASH VTE Clinical Practice Guidelines


Date/Time: Tuesday, January 29, 2019 at 12:00 PM - 1:00 PM EST
Faculty:  Shannon M. Bates, MDCM, MSc, FRCPC
Activity Medical Director:  Andra H. James, MD, MPH 
 

This state-of-the-science Webinar will review the new ASH VTE Clinical Guidelines and describe the current understanding and practice as applied to pregnancy. The proposed Webinar will have a special focus on the strengths and limitations of the guidelines, the clinical importance, and the application to practice in the prevention diagnosis and treatment of VTE in pregnancy.   

Target Audience: Hematologists, pediatric/adolescent gynecologists, Ob/Gyn providers, nurse practitioners, and other healthcare providers

Learning Objectives:

  • Describe the process for developing the ASH VTE Clinical Guidelines, as well as their strengths and limitations
  • Distinguish the clinical importance of, and apply to practice, the ASH VTE Clinical Guidelines
  • Recognize and understand differences in recommendations in these guidelines compared to those developed by other organizations 
Credit Statement:
An application for continuing medical education has been submitted. 

 

REGISTER

 

This Webinar is supported in part by an educational grant from Grifols


Role of Selectins and Adhesion in the Pathiophysiology of Acute Vaso-occlusive Crisis in Sickle Cell Disease

Date/Time: Thursday, March 7, 2019 at 12:00 PM - 1:00 PM EST
Faculty:  Marilyn Telen, MD and Andra H. James, MD, MPH
  

This state-of-the-science Webinar will review the current best practices in the treatment and management of acute vaso-occlusive crisis in persons with sickle cell disease (SCD), and especially in pregnant women with SCD. The Webinar will have a special focus on the role of selectins in the pathophysiology of sickle cell disease acute vaso-occlusive crisis and its management, as well as describe state-of the-art treatments for patients, including females.

Target Audience: Hematologists, pediatric/adolescent gynecologists, Ob/Gyn providers, nurse practitioners, and other healthcare providers

Learning Objectives: 

  • Understand how adhesion and cell-cell interaction contribute to vaso-occlusion in sickle cell disease
  • Know the available new and state-of-the-science therapeutics/ treatments in the management of acute vaso-occlusive crisis in patients with sickle cell disease
  • Discuss the available treatments for vaso-occlusive crises in pregnant women

REGISTER

 
This Webinar is supported in part by an educational grant from Pfizer